Clinical Advances

An overview of mycobacterium tuberculosis infection after kidney transplantation

  • Shuyu ZHANG ,
  • Yuehong. LI
Expand
  • Department of Nephrology,Beijing Tsinghua Changgeng Hospital,Tsinghua Clinical Medical School,Tsinghua University,Beijing 102218,China

Received date: 2023-11-26

  Online published: 2024-07-30

Abstract

Tuberculosis in kidney transplant(KT) recipients is a common opportunistic infection with higher incidence and prevalence than in the general population. Tuberculosis infection after kidney transplantation included latent tuberculosis infection, inactive tuberculosis infection and active tuberculosis infection. The following factors should be considered in the diagnosis of tuberculosis infection in KT recipients: atypical clinical presentation, association with co-infections, decreased predictive values of screening tests, diverse imaging findings and particular diagnostic methods. Regarding treatment challenges in KT recipients with tuberculosis, course of treatment, drug interaction, drug toxicity and therapeutically adherence should be considered.

Cite this article

Shuyu ZHANG , Yuehong. LI . An overview of mycobacterium tuberculosis infection after kidney transplantation[J]. The Journal of Practical Medicine, 2024 , 40(15) : 2047 -2050 . DOI: 10.3969/j.issn.1006-5725.2024.15.001

References

1 KARUTHU S, BLUMBERG E A. Common infections in kidney transplant recipients[J]. Clin J Am Soc Nephrol, 2012, 7(12):2058-2070. doi:10.2215/cjn.04410512
2 KWON D E, HAN S H, HAN K D, et al. Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high-endemic country[J]. Transpl Infect Dis, 2021, 23(6):e13729. doi:10.1111/tid.13729
3 BUMBACEA D, AREND S M, EYUBOGLU F, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement[J]. Eur Respir J, 2012, 40(4):990-1013. doi:10.1183/09031936.00000712
4 SOROHAN B M, ISMAIL G, TACU D, et al. Mycobacterium Tuberculosis Infection after Kidney Transplantation: A Comprehensive Review[J]. Pathogens, 2022, 11(9):1041. doi:10.3390/pathogens11091041
5 MAMISHI S, POURAKBARI B, MORADZADEH M, et al. Prevalence of active tuberculosis infection in transplant recipients: A systematic review and meta-analysis[J]. MicrobPathog, 2020, 139:103894. doi:10.1016/j.micpath.2019.103894
6 MORRIS M I, DALY J S, BLUMBERG E, et al. Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report[J]. Am J Transplant, 2012, 12(9):2288-300. doi:10.1111/j.1600-6143.2012.04205.x
7 CHAN S, PASCOE E M, CLAYTON P A, et al. Infection-Related Mortality in Recipients of a Kidney Transplant in Australia and New Zealand[J]. Clin J Am Soc Nephrol, 2019, 14(10):1484-1492. doi:10.2215/cjn.03200319
8 COSTA S D, DE SANDES-FREITAS T V, JACINTO C N, et al. Tuberculosis after kidney transplantation is associated with significantly impaired allograft function[J]. Transpl Infect Dis, 2017. doi: 10.1111/tid.12750 .
9 SUBRAMANIAN A K. Tuberculosis in solid organ transplant candidates and recipients: current and future challenges[J]. Curr Opin Infect Dis, 2014, 27(4): 316-321. doi:10.1097/qco.0000000000000082
10 RASHID H U, BEGUM N A S, KASHEM T S. Mycobacterial infections in solid organ transplant recipients[J]. Korean J Transplant, 2021, 35(4):208-217. doi:10.4285/kjt.21.0033
11 SHU C C, TSAI M K, LIN S W, et al. Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control[J]. Clin Infect Dis, 2020, 71(4):914-923. doi:10.1093/cid/ciz851
12 SHINGDE R, HABACHOU L I, CALISA V, et al. Unexpected donor-derived infectious transmissions by kidney transplantation: A systematic review[J]. Transpl Infect Dis, 2018, 20(2):e12851. doi:10.1111/tid.12851
13 O'GARRA A, REDFORD P S, MCNAB F W, et al. The immune response in tuberculosis[J].Annu Rev Immunol, 2013, 31:475-527. doi:10.1146/annurev-immunol-032712-095939
14 ESWARAPPA M, H J G D, JOHN M M, et al. Tuberculosis in renal transplant recipients: Our decade long experience with an opportunistic invader[J]. Indian J Tuberc, 2020, 67(1):73-78. doi:10.1016/j.ijtb.2019.05.001
15 BADDELEY A, BARTENS M, DEN BOON S, et al. World Health Organization. Global tuberculosis report. 2021[EB/OL][2023-11-26]. .
16 RAHIMIFARD N, MAHMOUDI S, MAMISHI S, et al. Prevalence of latent tuberculosis infection in transplant candidates: A systematic review and meta-analysis[J]. MicrobPathog, 2018, 125:401-410. doi:10.1016/j.micpath.2018.09.040
17 KRISHNAMOORTHY S, KUMARESAN N, ZUMLA A. Latent tuberculosis infection and renal transplantation-Diagnosis and management[J]. Int J Infect Dis, 2019, 80S:S73-S76. doi:10.1016/j.ijid.2019.01.049
18 KIM S H, LEE S O, PARK J B, et al. A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients[J]. Am J Transplant, 2011, 11(9):1927-1935. doi:10.1111/j.1600-6143.2011.03625.x
19 蒋文明,钱朝霞. 结核分枝杆菌特异性干扰素-γ和白介素-2联合检测对肺结核的辅助诊断价值[J]. 实用医学杂志, 2022, 38(16): 2114-2116.
20 SHU C C, TSAI M K, LIN S W, et al. Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control[J]. Clin Infect Dis, 2020, 71(4):914-923. doi:10.1093/cid/ciz851
21 刘志辉, 刘健雄. 结核病临床诊疗和流行控制对医学检验的需求、问题与对策 [J]. 实用医学杂志, 2023, 39(11): 1342-1346. doi:10.3969/j.issn.1006-5725.2023.11.004
22 SUBRAMANIAN A K, THEODOROPOULOS N M. Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation[J]. Clin Transplant, 2019, 33(9):e13513. doi:10.1111/ctr.13513
23 ZHANG L, SHI X, ZHANG Y, et al. Analysis of Factors Influencing Diagnostic Accuracy of T-SPOT.TB for Active Tuberculosis in Clinical Practice[J]. Sci Rep, 2017, 7(1):7764. doi:10.1038/s41598-017-07785-6
24 ABAD C L R, RAZONABLE R R. Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: A comprehensive review[J]. Transpl Infect Dis, 2018, 20(5):e12971. doi:10.1111/tid.12971
25 MEIJE Y, PIERSIMONI C, TORRE-CISNEROS J, et al. Mycobacterial Infections in Solid Organ Transplant Recipients[J]. Clin Microbiol Infect, 2014, 20 (): 89-101. doi:10.1111/1469-0691.12641
26 SASI S, VARGHESE M K, NAIR A P, et al. Tuberculosis in an Allogeneic Transplant Kidney: A Rare Case Report and Review of Literature[J]. Cureus, 2020, 12(11):e11661.
27 中华医学会器官移植学分会. 器官移植术后结核病临床诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(4): 359-363. doi:10.3969/j.issn.1674-7445.2019.04.003
28 ALEMU A, BITEW Z W, DIRIBA G, et al. Tuberculosis incidence in patients with chronic kidney disease: a systematic review and meta-analysis[J]. Int J Infect Dis, 2022, 122:188-201. doi:10.1016/j.ijid.2022.05.046
29 刘俊志,曾军,等. 异烟肼针对性预防肾移植受者结核潜伏感染的回顾性研究[J]. 实用医学杂志, 2022, 38(13): 1609-1613. doi:10.3969/j.issn.1006-5725.2022.13.008
30 杨子龙,袁园, 等. 糖尿病与肺结核共病结核分枝杆菌耐药情况分析[J]. 实用医学杂志, 2023, 39(11): 1359-1363. doi:10.3969/j.issn.1006-5725.2023.11.007
Outlines

/